FDA turns down Leukemia Drug

Posted on July 1, 2005 by David Austin
  • Email This
  • Print
  • Trackbacks
  • Share Link

The FDA turned down a Johnson & Johnson application for a new experimental leukemia drug.  The drug was called tipifarnib.

Tipifarnib is an oral medication studied to treat acute myeloid leukemia in elderly patients who are not candidates for standard chemotherapy.

Source:  Reuters at Yahoo

Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.benzeneleukemialawblog.com/admin/trackback/59056
Comments (0) Read through and enter the discussion with the form at the end
Send To A Friend Use this form to send this entry to a friend via email.